Activating types 1 and 2 angiotensin II receptors modulate the hypertrophic differentiation of chondrocytes

FEBS Open Bio

Volumn 3, Issue , 2013, Pages 279-284

  Tsukamoto, Ichiro ^a   Inoue, Shinji ^a   Teramura, Takeshi ^a   Takehara, Toshiyuki ^a   Ohtani, Kazuhiro ^a   Akagi, Masao ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Angiotensin II type 1 receptor; Angiotensin II type 2 receptor; ATDC5; Hypertrophic differentiation; Local RAS

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; COLLAGEN TYPE 10; COLLAGENASE 3; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 84880399761     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2013.07.001     Document Type: Article

References (23)

1. Tigerstedt R., Bergman P.G. Niere und Kreislauf. Skand. Arch. Physiol. 1898, 8:223-271. [in German].
2. Marks L.S., Maxwell M.H. Tigerstedt and the discovery of renin. An historical note. Hypertension 1979, 1:384-388.
3. Paul M., Poyan Mehr A., Kreutz R. Physiology of local renin-angiotensin systems. Physiol. Rev. 2006, 86:747-803.
4. Morris R.S., Francis M.M., Do Y.S., Hsueh W.A., Lobo R.A., Paulson R.J. Angiotensin II (AII) modulation of steroidogenesis by luteinized granulosa cells in vitro. J. Assist. Reprod. Genet. 1994, 11:117-122.
5. Hagemann A., Nielsen A.H., Poulsen K. The uteroplacental renin-angiotensin system: a review. Exp. Clin. Endocrinol. 1994, 102:252-261.
6. Garcia P., Schwenzer S., Slotta J.E., Scheuer C., Tami A.E., Holstein J.H., et al. Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation - role of a local renin-angiotensin system. Br. J. Pharmacol. 2010, 159:1672-1680.
7. Price A., Lockhart J.C., Ferrell W.R., Gsell W., McLean S., Sturrock R.D. Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis. Arthritis Rheum. 2007, 56:441-447.
8. Shimizu H., Nakagami H., Osako M.K., Hanayama R., Kunugiza Y., Kizawa T., et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J. 2008, 22:2465-2475.
9. Rejnmark L., Vestergaard P., Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J. Hypertens. 2006, 24:581-589.
10. Hagiwara H., Hiruma Y., Inoue A., Yamaguchi A., Hirose S. Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J. Endocrinol. 1998, 156:543-550.
11. Bandow K., Nishikawa Y., Ohnishi T., Kakimoto K., Soejima K., Iwabuchi S., et al. Low-intensity pulsed ultrasound (LIPUS) induces RANKL, MCP-1, and MIP-1beta expression in osteoblasts through the angiotensin II type 1 receptor. J. Cell. Physiol. 2007, 211:392-398.
12. Steckelings U.M., Kaschina E., Unger T. The AT2 receptor - a matter of love and hate. Peptides 2005, 26:1401-1409.
13. Nakajima M., Hutchinson H.G., Fujinaga M., Hayashida W., Morishita R., Zhang L., et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:10663-10667.
14. AbdAlla, S., Lother, H., Abdel-tawab, A.M., Quitterer, U. (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J. Biol. Chem. 276, 39721-39726.
15. Alexander S.P.H., Mathie A., Peters J.A. Guide to Receptors and Channels (GRAC), 4th edition. Br. J. Pharmacol. 2009, 158:S1-S254.
16. Miura S., Fujino M., Hanzawa H., Kiya Y., Imaizumi S., Matsuo Y., et al. Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor. J. Biol. Chem. 2006, 281:19288-19295.
17. Miura S., Fujimoto M., Saku K. Angiotensin II receptor blocker as an inverse agonist. Curr. Hypertens. Rev. 2005, 1:115-121.
18. Seifert R., Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch. Pharmacol. 2002, 366:381-416.
19. 1 receptor: influence of the size of the agonist switch binding residue Asn(111). Biochemistry 1998, 37:15791-15798.
20. Steckelings U.M., Larhed M., Hallberg A., Widdop R.E., Jones E.S., Wallinder C., et al. Non-peptide AT2-receptor agonists. Curr. Opin. Pharmacol. 2011, 11:187-192.
21. Mizuno M., Sada T., Ikeda M., Fukuda N., Miyamoto M., Yanagisawa H., et al. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. Eur. J. Pharmacol. 1995, 285:181-188.
22. Zou Y., Akazawa H., Qin Y., Sano M., Takano H., Minamino T., et al. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat. Cell. Biol. 2004, 6:499-506.
23. Barauna V.G., Magalhaes F.C., Campos L.C., Reis R.I., Kunapuli S.P., Costa-Neto C.M., et al. Shear stress-induced Ang II AT1 receptor activation: G-protein dependent and independent mechanisms. Biochem. Biophys. Res. Commun. 2013, 434:647-652.